MacKinnon, who heads a new medical education division and reports to managing director Marika Freris, said his aim was ‘to formalise and further develop Galliard’s med ed products and services’.
London-based Galliard wants to recruit ‘eight to ten’ people within a year to staff the division, he said.
MacKinnon left Cheshire-based CMC in April after ten years. He was latterly MD for three years.
Prior to CMC he worked at the former Glaxo for nine years in various clinical research and marketing jobs.
MacKinnon has known Freris for around seven years, with the duo having worked alongside each other on AstraZeneca business.
MacKinnon will continue to be based in Cheshire but is likely to spend around half the week in London.
‘Patients and doctors are increasingly scrutinising [clinical] data as it appears – the communications axis is therefore becoming more intertwined,’ he said.
Since he left CMC, MacKinnon has been doing consultancy work for various clients including a healthcare software firm.
At CMC he was replaced internally by the appointment of commercial director Charlie Buckwell.